Dharmesh Kant, Head of Research at Chola Securities, believes Reliance Jio's upcoming IPO is fairly valued and could deliver 20-25% listing gains as investors...
Shares of Dr Reddy's Laboratories Ltd. could rise another 37% from current levels, according to brokerage firm Nomura's latest note on Monday, June 22.Nomura...